PegBio Co., Ltd. (HKG:2565)
Hong Kong · Delayed Price · Currency is HKD 6.11
-0.09 (-1.45%)
Jun 18, 2026, 11:59 AM HKT
PegBio Market Cap
PegBio has a market cap or net worth of 2.42 billion as of June 17, 2026. Its market cap has decreased by -40.62% in one year.
Market Cap
2.42B
Enterprise Value
1.95B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6.11
Market Cap Chart
Since May 27, 2025, PegBio's market cap has decreased from 4.46B to 2.42B, a decrease of -45.65%. That is a compound annual growth rate of -43.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 2.42B | -91.01% |
| Dec 31, 2025 | 26.99B | 504.83% |
| May 27, 2025 | 4.46B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jacobio Pharmaceuticals Group | 3.64B |
| Qyuns Therapeutics | 3.60B |
| Medtide | 3.27B |
| Shandong Boan Biotechnology | 3.11B |
| Jiangsu Recbio Technology | 2.97B |
| BioDlink International Company | 2.79B |
| TYK Medicines | 2.65B |
| Viva Biotech Holdings | 2.52B |